Krishna Institute of Medical Sciences (KIMS) has announced plans to further increase its investment in Sarvejana Healthcare Private Limited (Sunshine Hospital) by up to ₹100 Crores. The board has approved this additional investment, which will be executed in one or more tranches. KIMS currently holds a 75.53% stake in Sunshine Hospital, and this move aims to strategically enhance their shareholding.
Additional Investment Approved
Krishna Institute of Medical Sciences Limited (KIMS) has received board approval to increase its investment in its material subsidiary, Sarvejana Healthcare Private Limited (Sunshine Hospital), by up to ₹100 Crores. This investment will be executed in one or more tranches to acquire shares from minority shareholders.
Sunshine Hospital Details
Sunshine Hospital is a material subsidiary of KIMS, with KIMS currently holding a 75.53% stake. As of the announcement date, Sunshine Hospital has a total paid-up equity share capital of ₹36,51,60,900. The turnover for the financial year ending March 31, 2025, was ₹597.00 Cr.
Strategic Rationale
The further investment in Sunshine Hospital is a strategic move to enhance KIMS’ shareholding. KIMS intends to invest up to ₹100 Crores in one or more tranches as a strategic investment to further enhance its shareholding.
Sunshine Hospital Financial Overview
Here’s an overview of Sunshine Hospital’s turnover for the past three financial years:
| FY25 | ₹597.00 Cr |
| FY24 | ₹464.20 Cr |
| FY23 | ₹419.44 Cr |
Background of Sunshine Hospital
Sunshine Hospital was established in May 2009, initially focusing on orthopedics, particularly joint replacements. It has since expanded to include other high-end healthcare services such as cardiology and transplants.
Source: BSE
